The Mycoplasma arthritidis antigen(s) responsible for eliciting metabolism-inhibiting antibodies in rabbits has been partially characterized. Metabolism-inhibiting activity was absorbed from rabbit antisera by intact M. arthrtidlis cells and membranes but much less so by the soluble cytoplasmic fraction, indicating that the antigen is located on the outer membrane surface. It was stable to periodate and lipid extraction but labile to heat and proteolytic enzymes, indicating that it is protein in nature. Finally, it is most likely a tightly bound integral rather than a peripheral membrane protein, since it was not extracted by low-ionic-strength solutions or by the nonionic detergents Triton X-100, Nonidet P-40, and Tween 20. It was solubilized by both the anionic agent sodium deoxycholate and the zwitterionic detergent Zwittergent14. Two monoclonal antibodies with metabolism-inhibiting activity were produced. One recognized a 45,000-dalton surface protein; however, the other recognized an antigen which is probably of cytoplasmic origin, indicating that more than one cell component may be involved in the metabolism-inhibiting antibody response.
Metabolism-inhibiting (MI) antibodies are considered protective in some mycoplasmal diseases; however, in the case of Mycoplasma arthritidis (8) , Mycoplasma pulmonis, Mycoplasma neurolyticum (9, 10) , Mycoplasma synoviae (21) , Mycoplasma gallisepticum (45) , and Mycoplasma hyosynoviae (50) MI antibodies are either absent or difficult to demonstrate in the natural host. In the case of at least three of these organisms, M. arthritidis, M. pulmonis, and M. neurolyticum, the defect does not appear to reside with the parasite, since guinea pigs and rabbits both produce MI antibodies in high titers against these mycoplasmas (10) . This apparent lack of expression by the natural host of antibodies directed against what are generally considered major membrane antigens remains unexplained. Cahill et al. (6) proposed that biological mimicry may prevent rats from recognizing the M. arthritidis "MI antigen(s)" as foreign. However, this remains to be confirmed. To study rat responses to the M. arthritidis antigens responsible for eliciting MI antibodies, it was first necessary to characterize them in greater detail. We shall use the term MI antigen to refer to the cellular components responsible for eliciting MI antibodies, with the understanding that more than one antigenic determinant may be involved in this reaction.
MATERIALS AND METHODS
Mycoplasmas and membrane preparations. M. arthritidis 158plO (15) and 158p10p9 (11) were grown in a dialysate medium modified from Kenny (26) and Washburn et al. (L. R. Washburn, W. J. Cathey, B. C. Cole, and J. R. Ward, Clin. Exp. Rheumatol., in press) or in a modified Hayflicktype medium (7) containing 70 g of PPLO Broth (Difco Laboratories, Detroit, Mich.) per liter and supplemented with 10o (vol/vol) horse serum, 5% (vol/vol) fresh yeast extract, 0.5% (wt/vol) L-arginine-HCl, and 250 U of penicillin per ml. Membranes were prepared by alkaline lysis of whole cells from 1-or 2-liter 18-to 24-h cultures (13) and washed and separated from unlysed cells by sucrose gradient ultracentrifugation, as described by Razin and Rottem (37) . The soluble fraction was dialyzed against 0.01 M phosphatebuffered 0.15 M NaCl (pH 7.4; PBS) and water and lyophilized. Before use, the lyophilized residue was reconstituted with approximately 1 ml of water per liter of original culture medium. Protein determinations were by the method of Lowry et al. (33) .
Preparation of rabbit antisera. Two rabbits, designated R2 and L2, were immunized with M. arthritidis 158plO. Rabbit R2 received 8 x 108 CFU of viable M. arthritidis by intra-articular injection and was killed by exsanguination under pentobarbital anesthesia 8 weeks later. Rabbit L2 received 1 x 109 CFU intra-articularly and at 5 weeks was boosted with 3 x 109 CFU intravenously. L2 was killed by exsanguination 1 week after the booster injection. A third rabbit was immunized against 158p10p9 as done for rabbit L2. All mycoplasmas for rabbit injections were grown in the dialysate medium.
Biochemical and detergent treatments of mycoplasma membranes. One-milligram (protein) quantities of M. arthritidis membranes were treated with 0.005 M NaIO4 for 1 h at room temperature or with 0.2% (wt/vol) trypsin, 0.1% (wt/vol) protease (type VI, Streptomyces griseus), or 0.1% (wt/vol) chymotrypsin for 1 h at 37°C. These reagents were purchased from Sigma Chemical Co., St. Louis, Mo.; all solutions were made in PBS. The treated membranes were washed twice with PBS to remove the reagents before use in immunoblotting and absorption experiments.
Membranes (5 mg of protein) were extracted with cold butanol as described by Rodwell et al. (38) . The butanol (lipid-enriched) phase was dried under N2 and stored at 4°C, and the aqueous (lipid-depleted) phase was dialyzed exhaustively against PBS and stored lyophilized until use.
For detergent extraction of membrane proteins, 1-mg quantities of membranes were treated for 30 min at 37°C with 1% (wt/vol) sodium deoxycholate (NaDOC; Sigma), 0.5% (vol/vol) Triton X-100 (Sigma), 0.5% (vol/vol) Nonidet P-40 (NP-40; BDH, Poole, England), 1.0% (vol/vol) Tween 20 (J. T. Baker Chemical Co., Phillipsburg, N.J.), or 1.2% 358 WASHBURN, RAMSAY, AND ROBERTS (wt/vol) Zwittergent3 14 (Calbiochem-Behring, La Jolla, Calif.). These solutions also were made in PBS. After treatment, the undissolved membrane residues were washed twice with PBS to remove the detergents. The NaDOC-and Zwittergent3 14-extracted membrane proteins were treated twice to remove the detergent by batch extraction with SM-2 Bio-Beads (Bio-Rad Laboratories, Richmond, Calif.) by the procedure described by Holloway (18) , followed by exhaustive dialysis against PBS. They were stored lyophilized.
Samples of the extracts were removed for electrophoresis before removal of detergent.
Quantities (100 pLg) of strain 158plO membranes were electrophoresed on 10% (wt/vol) polyacrylamide slab gels containing 0.1% (wt/vol) sodium dodecyl sulfate (SDS). The gels were then stained for protein with Coomassie blue and for glycoproteins with the periodic acid Schiff stain as described by Segrest and Jackson (41 Fourteen days later, the supernatants from wells containing hybridoma cells were screened for antibody activity by the MI assay described below. Positive hybridomas were selected, expanded to 1-ml cultures in 24-well plates, and cloned on thymocyte feeder layers by the limiting dilution technique (25) . Monoclonal antibody-containing ascites fluids were obtained from BALB/c mice which had been inoculated with 2 x 106 hybridoma cells 14 days after intraperitoneal injection of 0.5 ml of pristane. Mouse anti-158plOp9 antiserum was collected after membrane challenge from a BALB/c mouse immunized as described for the mouse from which the hybridomas were derived. This antiserum had an MI titer of 320.
Immunological techniques. The MI assay was performed by the method of Purcell et al. (35) as modified by Washburn (48) .
For immunoblotting experiments, the treated residues from 20 jig of membranes or 20-,ug quantities of untreated membranes were electrophoresed by SDS-polyacrylamide gel electrophoresis (PAGE) and transferred electrophoretically overnight to nitrocellulose paper in a Bio-Rad Transblot apparatus. For certain experiments, antigens other than mycoplasma membranes were used; these also were electrophoresed in 20-,ug quantities. To this were added 100 ,uCi of Na125I (New England Nuclear Corp., Boston, Mass.), 10 RI of lactoperoxidase (1 mg/ml; Sigma), 10 RI (10 mU) of glucose oxidase (8 ,ug/ml; Sigma), and 10 RI of 2 M glucose. The enzyme and glucose solutions were prepared with 0.05 M phosphate buffer (pH 7.4). After 10 min of incubation at room temperature, the reaction was stopped with 10 pAl of 0.1 M sodium azide. The labeled cells then were lysed by adding 2 ml of 1% (wt/vol) NaDOC in 0.01 M Tris-buffered 0.15 M NaCI (pH 8.3) (1% DOC-Tris), and the mixture was stirred for an additional 10 min. It then was desalted in a disposable Sephadex G25 column (Pharmacia Fine Chemicals, Uppsala, Sweden) and concentrated by negative-pressure dialysis to Fig. 1) . Similar results were obtained with strain 158plOp9 and the original parent strain 158 (not shown). In addition, the lipid-depleted 158plOp9 membrane fraction retained all the major antigens identifiable by immunoblotting, whereas very few were present in the lipid fraction (Fig. 2) .
To determine the effect of these treatments on the MI antigen, we absorbed 0.25-ml quantities of 1:20-diluted anti158plOp9 antiserum with the residues from 1-mg quantities of enzyme-and peroidate-treated and lipid-and proteindepleted 158plOp9 membranes. In addition, we absorbed 0.25-ml quantities of 1:5-diluted anti-158plO antiserum (R2) with untreated intact 158plO cells and cells which had been membrane components showed no evidence of glycoproteins (not shown).
Detergent solubility of M. arthritidis membrane antigens. To determine the effect of detergent extraction of M. arthritidis membrane antigens, we prepared immunoblots of the insoluble residues from Tween 20-, NP-40-, NaDOC-, and Zwittergent3 14-treated membranes. We omitted Triton X-100 from this experiment since it is identical to NP-40. The nonionic detergents Tween 20 and NP-40 did not alter the antigenic profile, whereas NaDOC was much more effective at solubilizing membrane proteins, and the zwitterionic detergent Zwittergent3 14 was even more so (Fig. 3) . Figure 4 shows more clearly the effect of NaDOC. Most of the membrane antigens were present in the NaDOC extract, which showed an antigenic profile similar to that of unextracted membranes. In this experiment, NaDOC extraction was somewhat more effective than that in the experiment illustrated in Fig. 3 . Membrane proteins extracted by Zwittergent3 14 also showed an antigenic profile identical to that of unextracted membranes (not shown).
Next, we absorbed 0.25-ml quantities of 1:20-diluted anti158plO (L2) and anti-158plOp9 antisera with the residues from detergent-extracted membranes. As expected from the immunoblotting results, membranes treated with Triton X-100, NP-40, and Tween 20 still retained the MI antigen and strongly absorbed MI antibody, whereas the NaDOC-and Zwittergent3 14-treated membranes did not. We removed NaDOC from 158plOp9 solubilized proteins as described above and absorbed the anti-158plOp9 antiserum with this extract. The solubilized proteins absorbed as much MI activity as did intact membranes (Table 3) . We repeated this experiment with both NaDOC-and Zwittergent3 14-solubilized 158plO proteins. This time, the extracts reduced the anti-158plO (L2) MI titer by 16-fold (not shown), thus confirming that these detergents left the MI antigen at least partially antigenically intact. (Fig. 5) . This antibody recognized an identical antigen on the 158plO membrane (not shown). We also tested this antibody by RIP against 1251I-labeled whole cells which had been lysed by NaDOC before labeling, so that cytoplasmic and inner surface membrane proteins were labeled as well. It did not react with any labeled M. arthritidis cell component other than the 45K-dalton membrane protein (results not shown).
The other MI-active monoclonal antibody, F11.10, did not react with membrane proteins by RIP or immunoblotting (Fig. 5) , but it did react by immunoblotting with a 77K-dalton peptide present in both whole cells and the soluble fraction (Fig. 6) tigators studying immunological aspects of mycoplasma infection (4, 27, 32, 34, 40, 46, 49) . To minimize interference by anti-medium antibodies in the present study, we used mycoplasmas grown only in the dialysate medium for rabbit immunizations. The resulting antisera showed titers by enzyme immunoassay against whole horse serum of 20 for the R2 anti-158plO and anti-158plOp9 antisera and <20 for the L2 anti-158plO antiserum. We tested the two rabbit antisera used in the immunoblotting experiments described in this report (L2 anti-158plO and anti-158plOp9) by immunoblotting against whole horse serum, the boiled agamma fraction, and the complete dialysate medium. In addition, we compared the reactivity of these antisera for M. arthritidis membranes prepared from organisms grown in the Hayflicktype and the dialysate media (Fig. 7) . Neither of these antisera reacted significantly with either of the horse serum preparations or with the medium used to grow their respective immunogens, even though the antisera were tested against concentrations of medium antigens far in excess of those amounts which might be expected to contaminate membrane preparations. In addition, the immunoblots of Hayflick-type and dialysate media-grown membranes were nearly identical (Fig. 7) . These results indicated to us that the antigens recognized in the immunoblotting experiments reported here were not of medium origin and that medium contamination of mycoplasma antigen preparations did not affect the results of this study.
DISCUSSION
Host contact with most of the pathogenic mycoplasmas occurs first with antigens on the limiting plasma membrane. Therefore, these antigens take on a significance as great as those of bacterial cell walls in host-parasite interaction. In addition, Mycoplasma species are obligate parasites and reside in close cell-to-cell contact with their hosts. Some species attach through receptors which can be blocked by specific antibodies (19, 29) . The lack of a rigid cell wall plus this very close mycoplasma-host cell interaction make the study of mycoplasma membrane antigens a critical part of any study of mycoplasma pathogenesis. We (39, 44) .
For Mycoplasma mycoides the major antigens are carbohydrate (5, 22) . In the case of at least three mycoplasmas, Mycoplasma fermentans, Mycoplasma hominis, and M. pulmonis, the major membrane antigens are protein (2, 17) .
The present study indicates that M. arthritidis may be counted among this group as well. Glycoproteins are rare among procaryotes; however, one has been identified in M. pneumoniae (23, 24) and tentatively in M. gallisepticum (14) , although the latter has not been confirmed (1 (30) . The MI antigen is apparently an integral part of the membrane, hydrophobically rather than covalently bound, since it persisted through the numerous washes with lowionic-strength solutions that are part of the membrane preparation procedure, and it was difficult to extract with nonionic detergents. We found the zwitterionic detergent Zwittergent3 14 to be the most successful among those tested at solubilizing M. arthritidis membrane antigens, and solubilization in both NaDOC and Zwittergent314 left the MI antigen at least partly intact. Since these agents can be removed by adsorption with polystyrene beads, followed by dialysis, it should be possible to prepare highly purified M. arthritidis membrane antigens, starting with NaDOC or Zwittergent extraction.
An IgG monoclonal antibody with MI activity reacted by immunoblotting and RIP with a single 45K-dalton membrane protein. The RIP results indicated that the MI antigen defined by this monoclonal antibody was located on the cell surface, since the lactoperoxidase-glucose oxidase iodination procedure labels only surface proteins. This major antigen was susceptible to proteolytic enzymes ( Fig. 1) and soluble in both NaDOC and the zwitterionic detergent ( Fig.  3 and 4) . It is interesting that rats, which do not express MI antibody against M. arthritidis, nevertheless produce an IgG antibody against this antigen, as seen by immunoblotting and RIP (L. R. Washburn, J. R. Ramsay, and D. Asbury, manuscript in preparation). Explanations for the lack of MI activity in rats might include: (i) the recognition by this antibody of a slightly different antigenic determinant than is involved in the MI reaction, (ii) steric hindrance by another antibody or medium-derived component during the course of the MI assay, or (iii) the inability of this antibody to fix complement, which may participate in the MI reaction (27 
